COVID-19 global registry data key in rheumatic disease management

Data from U.S. and European COVID-19 registries of patients with rheumatic diseases have yielded actionable information to help rheumatologists manage patients with the virus, according to data presented at EULAR 2022 Congress.
“Our patients, and doctors, and other health care professionals, they were all very worried because, potentially, they could be at risk for severe disease and severe outcomes for SARS-CoV-2 infection,” Pedro Machado, MD, associate professor and consultant in rheumatology and neuromuscular diseases at University College London, University College Hospital,

Data from U.S. and European COVID-19 registries of patients with rheumatic diseases have yielded actionable information to help rheumatologists manage patients with the virus, according to data presented at EULAR 2022 Congress.
“Our patients, and doctors, and other health care professionals, they were all very worried because, potentially, they could be at risk for severe disease and severe outcomes for SARS-CoV-2 infection,” Pedro Machado, MD, associate professor and consultant in rheumatology and neuromuscular diseases at University College London, University College Hospital,